T. Rowe Price Associates’s Praxis Precision Medicines PRAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$203M	Sell	630,852 -155,135	-20%	-$48M	0.02%	459
2025 Q4	$232M	Sell	785,987 -217,503	-22%	-$40.5M	0.03%	424
2025 Q3	$53.2M	Sell	1,003,490 -469,585	-32%	-$22.8M	0.01%	794
2025 Q2	$61.9M	Buy	1,473,075 +377,350	+34%	+$14.4M	0.01%	678
2025 Q1	$41.5M	Sell	1,095,725 -112,797	-9%	-$7.04M	0.01%	775
2024 Q4	$93M	Buy	1,208,522 +88,442	+8%	+$6.4M	0.01%	576
2024 Q3	$64.5M	Buy	1,120,080 +181,501	+19%	+$9.8M	0.01%	684
2024 Q2	$38.8M	Buy	938,579 +402,580	+75%	+$19M	﹤0.01%	796
2024 Q1	$32.7M	Buy	+535,999	New	+$24M	﹤0.01%	836
2023 Q2	–	Sell	-2,692	Closed	-$33K	–	2930
2023 Q1	$33K	Sell	2,692 -504	-16%	-$21.3K	﹤0.01%	2824
2022 Q4	$114K	Buy	3,196 +822	+35%	+$25.6K	﹤0.01%	2688
2022 Q3	$81K	Sell	2,374 -357	-13%	-$17.8K	﹤0.01%	2771
2022 Q2	$100K	Buy	2,731 +896	+49%	+$95.6K	﹤0.01%	2754
2022 Q1	$281K	Buy	1,835 +53	+3%	+$10.9K	﹤0.01%	2574
2021 Q4	$527K	Buy	1,782 +398	+29%	+$117K	﹤0.01%	2363
2021 Q3	$384K	Buy	+1,384	New	+$375K	﹤0.01%	2486